Navigation Links
Molecular Devices Enables Intuitive Functionality at Your Fingertips on the Apple iPad with the Latest SoftMax Pro Software
Date:7/12/2011

SUNNYVALE, Calif., July 12, 2011 /PRNewswire/ -- Molecular Devices Inc., a leader in bioanalytical systems for drug discovery & development, life science research, and bioassay/test development, today announced that it has expanded the functionality of the SoftMax® Pro Software and prominence of the SpectraMax® microplate readers, enabling monitor and control ability via an Apple iPad wireless device.

(Logo: http://photos.prnewswire.com/prnh/20100406/SF82092LOGO)

When the iPad is used together with SoftMax Pro Software, it is possible to simultaneously monitor and control the operating and usage conditions of SpectraMax microplate reader. Displayed via an intuitive interface, many tasks that previously required a trip to the lab can now be performed wirelessly with the iPad. The mobility and document browsing features of the iPad can provide additional gains in laboratory efficiency through quick and easy access to important information.

"This latest enhancement to our SoftMax Pro Software opens a new dimension for data analysis on the SpectraMax readers," says Mikey Kindler, Director of Marketing, BioResearch Products. "This seamless interface enables microplate reader control and remote monitoring possibilities, placing protocols and data into the hands of researchers - wherever they are."

The following improvements in task efficiency can be achieved using the new functionality:


  • Increased efficiency through protocol monitoring of your microplate readerFree up your time by monitoring protocols and operating status. The status of your SpectraMax reader in the laboratory can be checked quickly from remote locations. If an error occurs, equipment instruction manuals can be referenced immediately, enabling rapid troubleshooting and response. The result is more reliable execution of analysis tasks and overall improvement in task efficiency.


  • Improved sharing of your data acquisitions and analysisSoftMax Pro affords the capability to share your data and analysis with anyone, from anywhere in the world, by opening-up a new world of remote connectivity by using the Apple iPad.For more details contact your Molecular Devices' sales representative.

    About Molecular Devices: At Molecular Devices we have one focus—our customers. When you become our customer, your needs drive our actions and your success is our concern. Our instruments offer a full spectrum of detection technologies and meet all throughput and content needs. Our goal is to deliver highly relevant bioanalytical products to detect biology, decode data, and drive discovery.

    Global Sales & Support Offices:  N America: 1 800 635 5577, Brazil: +55 11 3616 6607; UK: +44 118 944 8000; Germany: +49 89/96 05 88 0; China: +86 10 6410 8669 (Beijing), +86 21 33721088 (Shanghai); Japan: +81 6 6399 8211 (Osaka), +81 3 5282 5261 (Tokyo); S Korea: +82 2 3471 9531

    All products are FOR RESEARCH USE ONLY. Not for Use in Diagnostic Procedures.

    All trademarks are the property of Molecular Devices, Inc.

    iPad is a trademark of Apple Inc., registered in the U.S. and other countries.
    '/>"/>


  • SOURCE Molecular Devices Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
    2. Molecular sleuths track evolution through the ribosome
    3. VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent
    4. PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
    5. Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC
    6. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
    7. Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
    8. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
    9. LI-COR Introduces the Odyssey(R) Two-Color NIR Fluorescent Protein Molecular Weight Marker
    10. Vineland Welcomes Dr. Daryl Somers as Research Chair, Molecular Breeding and Biotechnology
    11. Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized Moderate Complexity by FDA
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2017)... Toronto, Canada (PRWEB) , ... May 23, 2017 ... ... of Firmex FileSend, a cloud-based file transfer solution that makes it easy for ... firewall without having to worry about cumbersome FTP software or email file size ...
    (Date:5/23/2017)... Ca (PRWEB) , ... May ... ... (PSCs) offer an unlimited source of human cardiovascular cells for research and ... differentiation methods makes it possible to generate large numbers of cardiomyocytes (hPSC-CMs). ...
    (Date:5/23/2017)... ... 2017 , ... NetDimensions has been ranked as a Leader ... Corporate Learning, 2017. , Aragon Research defines Leaders as organizations who possess comprehensive ... those strategies. NetDimensions’ ranking as a Leader due to its strengths in: , ...
    (Date:5/23/2017)... PARK, CA (PRWEB) , ... May 23, 2017 , ... ... the publication of “Label-free isolation of prostate circulating tumor cells using Vortex microfluidic ... is the result of a collaboration with Dr. Dino Di Carlo and Dr. Matthew ...
    Breaking Biology Technology:
    (Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
    (Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
    (Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
    Breaking Biology News(10 mins):